Achieving breakthrough discoveries in small-molecule targeted therapeutics through expert integration of our unique biology insights, our cutting-edge technology platform, and globally networked operations
Modulus Discovery, Inc. to Change Its Name to Alivexis, Inc. on March 11, 2024
About Us
We are an international team of drug discovery scientists with extensive pharmaceutical, biotechnology, and computational R&D experience.